Cargando…
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal epithelial cells. Since there are currently no coded therapies or guidelines for treatment of COVID-19, this study aimed t...
Autores principales: | d'Ettorre, Gabriella, Ceccarelli, Giancarlo, Marazzato, Massimiliano, Campagna, Giuseppe, Pinacchio, Claudia, Alessandri, Francesco, Ruberto, Franco, Rossi, Giacomo, Celani, Luigi, Scagnolari, Carolina, Mastropietro, Cristina, Trinchieri, Vito, Recchia, Gregorio Egidio, Mauro, Vera, Antonelli, Guido, Pugliese, Francesco, Mastroianni, Claudio Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358304/ https://www.ncbi.nlm.nih.gov/pubmed/32733907 http://dx.doi.org/10.3389/fmed.2020.00389 |
Ejemplares similares
-
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021) -
Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021) -
Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021) -
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022) -
Is teicoplanin a complementary treatment option for COVID-19? The question remains
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)